Integrative Single-Cell and Bulk Transcriptome Analysis Reveals Molecular Mechanisms, Prognostic Signatures, and Therapeutic Response in Glioma.
This integrative analysis decodes the cellular architecture of glioma and establishes a robust neutrophil-associated prognostic model, offering a clinically relevant tool for risk stratification and precision treatment in glioma.